• Focus
  • Criteria
  • Team
  • Investments
  • Resources
  • News
  • Contact
 
Logo
  • Focus
  • Criteria
  • Team
  • Investments
  • Resources
  • News
  • Contact

Oculogica has been awarded a US patent to detect CTE via its eye tracking technology

by Sofia Fund | Jun 24, 2021 | Portfolio Company News

This is a major innovation as CTE (chronic traumatic encephalopathy) is currently only diagnosed after death.

Read full press release here.

Tags: Oculogica

Older post: Joylux announces new expanded products to support women through menopause
Newer post: Neurology Clinic Will Use Oculogica’s EyeBox to Detect Concussions in Patients

News Categories

  • Sofia Fund Blog (7)
  • Sofia Fund News (24)
  • Sofia Fund Investments (4)
  • Portfolio Company News (33)
  • Angel and VC Investment News (4)
  • Women Entrepreneurship (1)
  • CogRx
  • Joylux
  • Landit
  • Oculogica
  • Strategikon Pharma
  • TiLT

© Copyright 2026 Sofia Fund. All Rights Reserved.   |   Privacy Policy